Pages
Products
Human DMD Knockout Cell Line-HeLa

Human DMD Knockout Cell Line-HeLa

Cat.No. :  CSC-RT0606

Host Cell:  HeLa Target Gene:  DMD

Size:  1x10^6 cells/vial, 1mL Validation:  Sequencing

Inquire for Price

Cell Line Information

Cell Culture Information

Safety and Packaging

Gene Informationn

Cat. No. CSC-RT0606
Description A stable cell line with a homozygous knockout of human DMD using CRISPR/Cas9.
Target Gene DMD
Host Cell HeLa
Host Cell Species Homo sapiens (Human)
Shipping 10^6 cells/tube
Storage Liquid nitrogen
Revival Rapidly thaw cells in a 37°C water bath. Transfer contents into a tube containing pre-warmed media. Centrifuge cells and seed into a 25 cm2 flask containing pre-warmed media.
Media Type Cells were cultured in DMEM supplemented with 10% fetal bovine serum.
Growth Properties Cells are cultured as a monolayer at 37°C in a humidified atmosphere with 5% CO2. Split at 80-90% confluence, approximately 1:4-1:6.
Freeze Medium Complete medium supplemented with 10% (v/v) DMSO
Gene Name
Gene ID
Mycoplasma Negative
Format One frozen vial containing millions of cells
Storage Liquid nitrogen
Safety Considerations

The following safety precautions should be observed.

1. Use pipette aids to prevent ingestion and keep aerosols down to a minimum.

2. No eating, drinking or smoking while handling the stable line.

3. Wash hands after handling the stable line and before leaving the lab.

4. Decontaminate work surface with disinfectant or 70% ethanol before and after working with stable cells.

5. All waste should be considered hazardous.

6. Dispose of all liquid waste after each experiment and treat with bleach.

Ship Dry ice
Quick Inquiry

Background

Applications

Publications

Q & A

Customer Reviews

The dystrophin gene (DMD) is one of the longest known human genes, spanning approximately 2.4 megabases of DNA sequence. The DMD gene is located on the X chromosome at the Xp21.2 locus and is responsible for encoding dystrophin, a key protein involved in the structural integrity of muscle cells. Dystrophin is a key component of a protein complex that connects the internal cytoskeleton of the muscle fiber to the surrounding extracellular matrix through the cell membrane. This connection is essential for maintaining muscle cell stability during cycles of contraction and relaxation. Mutations in the DMD gene can cause muscular dystrophies, a group of muscle wasting disorders, the most severe of which is Duchenne muscular dystrophy (DMD). Duchenne muscular dystrophy affects approximately 1 in 3,500 to 5,000 live male births worldwide as it primarily affects males due to its X-linked recessive inheritance pattern. Females can be carriers of the mutation and may display milder symptoms. Loss or dysfunction of dystrophin due to the mutation leads to progressive muscle degeneration, resulting in symptoms such as muscle weakness, walking impairment, and severe cardiopulmonary complications. Early diagnosis is often facilitated by symptoms observed in early childhood, elevated serum creatine kinase levels, and genetic testing.
Human Duchenne Muscular Dystrophy Knockout Cell Line - HeLa refers to HeLa cells in which the dystrophin gene (DMD) has been knocked out. Here are some of the key applications: Duchenne Muscular Dystrophy Research: DMD Knockout HeLa cells help study Duchenne Muscular Dystrophy (DMD) to better understand the molecular mechanisms and pathways involved in the disease. This helps identify potential targets for therapeutic intervention. Drug Screening and Development: DMD Knockout HeLa cells can be used to screen for new drugs that can improve or treat symptoms associated with DMD. The lack of dystrophin in these cells allows for the evaluation of compounds for efficacy and toxicity. Protein Interaction Studies: Researchers can study how the lack of dystrophin affects other protein interactions within the cell. This can reveal new insights into cellular processes disrupted by the mutation and identify secondary targets for treatment. Pathway Analysis: Using these knockout cells, scientists can analyze changes in signaling pathways and cellular responses due to the loss of dystrophin.
Customer Q&As
What is the recommended growth medium? Does it require antibiotic selection?

A: DMEM supplemented with 10% fetal bovine serum.
It is not required to add the selection antibiotics when culturing the KO cells.

How is the knockout cell line validated?

A: The knockout cell product is validated by PCR amplification and Sanger Sequencing to confirm the mutation at the genomic level. Please find the detailed mutation info in the datasheet.

Is the product a single clonal cell or mixed cell pool?

A: Single clonal cell.

Can I confirm gene knockout by RT-qPCR?

A: No. This knockout cell product is generated using the CRISPR/Cas9 system to induce small insertions or deletions (indels) resulting in frameshift mutations. Although these frameshift mutations typically disrupt the coding gene, there is a possibility that the non-functional transcript may still be transcribed. Consequently, this could potentially yield misleading results when analyzed by RT-qPCR.

How can I store the cell product?

A: The cell line should be stored in liquid nitrogen for long-term preservation.

Is it possible to get multiple knockout clones for my GOI?

A: For most cases, we often keep at least 2 clones with different frameshift mutations. Please feel free to contact us to check if there are additional available clones.

Ask a Question

If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.

Customer Reviews
Worked very well

I'm exploring ways to target dystrophin to treat muscular dystrophy. This DMD Knockout Cell Line is very helpful for our research.

United States

08/23/2020

Remarkable quality

The Human DMD Knockout Cell Line-HeLa is a breakthrough tool for researchers investigating the molecular mechanisms underlying Duchenne muscular dystrophy. Its remarkable quality and affordability make it accessible to labs worldwide, accelerating progress towards finding effective treatments.

United States

05/12/2021

High knockout efficiency

The Human DMD Knockout Cell Line-HeLa is a valuable resource for researchers aiming to develop novel therapies for Duchenne muscular dystrophy. Its robust phenotype and high knockout efficiency provide a reliable platform for testing potential treatments and evaluating their efficacy.

United States

08/15/2021

Reliable

The Human DMD Knockout Cell Line-HeLa is a reliable and cost-effective solution for investigating the role of dystrophin in muscle cell function. Its stable expression and efficient knockout efficiency provide a solid foundation for studying the pathophysiology of Duchenne muscular dystrophy and developing potential therapeutic strategies.

United States

10/09/2021

Write a Review

Write a review of your use of Biogene products and services in your research. Your review can help your fellow researchers make informed purchasing decisions.

Needs improvement

Satisfaction

General satisfaction

Very satisfaction

CBpromise

Our promise to you:
Guaranteed product quality, expert customer support.

24x7 CUSTOMER SERVICE
CONTACT US TO ORDER